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Abstract The poly(A)-binding protein (PABP) is a highly con-
served eukaryotic protein whose synthesis is regulated at the
post-transcriptional level. The binding of PABP to the poly-
(A)-rich element found in the 5P-untranslated region (5PUTR)
of PABP mRNA speci¢cally inhibits its own translation. In this
report, we show that similar adenosine-rich elements in the
5PUTR of the chloramphenicol acetyl-transferase (CAT) gene
can signi¢cantly reduce the reporter mRNA abundance and
translation in human 293 cells. The reduction in mRNA level,
but not CAT expression, is dependent on the size of the 5PUTR
poly(A) element. Furthermore, one 5PUTR-tethered PABP mol-
ecule is enough to inhibit CAT expression without a¡ecting its
mRNA level. We propose that the control of PABP synthesis
may involve mRNA decay and the repression of translation.
/ 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Messenger RNA translation and decay are tightly coupled
events [1]. However, the speci¢c correlation between transla-
tion inhibition in cis and mRNA decay is more controversial
[2^4]. Current data show that mRNA deadenylation precedes
decapping in mammalian cells [5] through changes in the in-
teractions between proteins that bring together the 5P and 3P
ends of mRNA [6]. Cross-talk between the mRNA 5P and 3P
ends is involved in the access of cap to the decapping complex
[7,8]. The involvement of the poly(A)-binding protein (PABP)
in mRNA circularization [9,10] and the initiation of transla-
tion [11^13] corroborates the ¢ndings that PABP plays a key
role in mRNA decay [14,15].
PABP expression is regulated by a translational repression
control mechanism that was ¢rst proposed by Sachs et al. [16].
The basis of the repression mechanism was con¢rmed in vitro
[17,18] and in vivo [19], and the binding of PABP to the
poly(A)-rich element (pARE) present within the 5P-untrans-
lated region (5PUTR) of its own mRNA was shown to be
responsible for stalling the 40S ribosomal subunit during
mRNA scanning [20]. In the presence of fetal calf serum
(FCS), PABP translation increases in mouse cells [21,22],
and the cells apparently respond to this stimulus through a
5P-terminal oligopyrimidine tract motif present in PABP
mRNA [23]. A third post-transcriptional mechanism control-
ling PABP expression may regulate the abundance of PABP
mRNA and depends on the cell type studied. In rat L6 myo-
blasts, di¡erentiation to myotubes decreases the steady-state
level of PABP mRNA [24], and in human 293 cells overex-
pression of ectopic PABP down-regulates the abundance of its
endogenous mRNA [25]. However, no mechanisms have been
proposed to explain the role of mRNA stability in the regu-
lation of PABP synthesis.
In this study, we show that the presence of the pARE found
within the 5PUTR of human PABP mRNA, or an equivalent
tract of contiguous adenosine residues placed in the 5PUTR of
the chloramphenicol acetyl-transferase (CAT) gene, can sig-
ni¢cantly reduce the abundance of reporter transcripts and
prevent their translation in human 293 cells. Moreover, the
length of the 5PUTR poly(A) elements can independently de-
termine the level of reporter transcripts and their susceptibility
to translation repression.
2. Materials and methods
2.1. Plasmids
The oligonucleotide primers pARE (CTAGCAGGCCTA6TCCA8-
TCTA7TCTTTTA6CCCCA7TTTACA6T) and 61As (CTAGCAGG-
CCTA61T) were originally cloned in the vector pTZ18R [17]. The
61As tract was substituted for the 20As and 10As tracts by digestion
with StuI and XbaI and ligation with one of two pairs of oligonucleo-
tide primers (CCTA20T and CCTA10T), respectively (Melo et al.,
submitted). pTZ18R-derived construct fragments were extracted
with SmaI^HindIII and inserted in the HindIII site of pSV2-CAT
[26] to produce pSV-pARE, pSV-61As, pSV-20As, and pSV-10As.
The recombinant plasmids pSV-pARE and pSV-61A were selected
for the two possible orientations to produce constructs with uridines
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in their 5PUTR (pSV-pURE (poly(U)-rich element) and pSV-61Us).
For the construction of MSC-15 and MSA-15, the human growth
hormone (GH) gene of the plasmids MSC-GH and MSA-GH [27]
was ¢rst replaced by the CAT gene through digestion with XbaI^
HindIII and ligation to the BamHI^HindIII fragment from pSV2-
CAT. To extend the distance between the MS2 (a viral coat protein)
binding site and cap, we inserted a 76 nt BamHI^XbaI fragment from
the polylinker region of plasmid pcDNA3 (Invitrogen) into the Bam-
HI site of MSC-15, producing the MSC-91 vector. The e¡ector plas-
mids were constructed by cloning the in-¢lled NcoI^SmaI fragment
from GST-PABP [17] into the in-¢lled XhoI site of the vectors pET15-
b (Novagen) and pET-MS2 [14]. The MS2, PABP and MS2/PABP
genes were subsequently extracted with XbaI^EcoRV and the in-¢lled
fragment cloned into the EcoRV site of pcDNA3 to produce the
plasmids pCMV-MS2, pCMV-PABP and pCMV-MS2/PABP, respec-
tively.
2.2. Cell culture and DNA transfection
Approximately 1U106 or 2U105 293-EBNA cells were grown in
six- or 24-well plates with Dulbecco’s modi¢ed Eagle’s medium sup-
plemented with 10% FCS (Life Technologies) and antibiotics, respec-
tively. Sub-con£uent cultures were transfected with LipofectAMINE
(Life Technologies), as recommended by the manufacturer. The six-
well transfection of pSV-CAT constructs was done using 1.1 Wg of
reporter plasmids and 0.1 Wg of pCMVL (Clontech). The 24-well
transfection of pSV-CAT constructs was done with 0.3 Wg of reporter
plasmids and 0.03 Wg of pCMVL. The six-well transfection of the
MSC-91 and MS2 constructs was done with 1.05 Wg of reporter plas-
mid, 0.05 Wg of e¡ector plasmid or pCDNA3 as a negative control,
and 0.1 Wg of pCMVL. The 24-well transfection of the reporters con-
taining the MS2 binding site and MS2 constructs was done with
0.25 Wg of reporter vector, 0.025 Wg of pCMVL, and 0.25 Wg of
pCDNA3, or with 0.25 Wg of reporter vector, 0.025 Wg of pCMVL
and 0.025 Wg of e¡ector plasmid.
2.3. Reporter enzyme assays, RNA isolation and Northern blotting
20 h after the transfection began, the cells of the 24-well assays were
washed twice in phosphate-bu¡ered saline (PBS), harvested and lysed
for the measurement of CAT and L-galactosidase (L-gal) as described
in [28]. The cells of the six-well assays were washed twice in PBS after
20 h of transfection and the total RNA was extracted with 800 Wl of
Trizol (Life Technologies), as recommended by the manufacturer. The
precipitated total RNA was re-suspended in 10 Wl of 1U DNase bu¡-
er (Pharmacia) and digested with 7 U of RNase-free DNase I (Phar-
macia) for 15 min at room temperature. The RNA (10 Wg) was loaded
into 1.2% formaldehyde-agarose gels, and Northern blotting was done
as previously described [29,30].
2.4. Molecular probes and measurement of mRNA levels
The isolated fragments used as probes in Northern blot analysis
were a 0.7 kb XbaI^HindIII fragment of pET-MS2 containing MS2,
a 1.6 kb HindIII^BamHI fragment of pSV2-CAT containing CAT, a
2.4 kb NcoI^SmaI fragment of GST-PABP containing the human
PABP cDNA, and a 3.5 kb ScaI^NotI fragment of pCMVL contain-
ing L-gal. Approximately 50 ng of each puri¢ed probe was labeled
with [K-32P]dCTP using the Megaprime kit (Pharmacia) and hybrid-
ization was done as described [30]. The sample pixel intensity of the
scanned radiograms was measured with Zero-Dscan software (Scana-
lytics).
3. Results
3.1. pAREs in the 5PUTR of CAT mRNAs reduce the reporter
activity regardless of its length and structure
To examine the e¡ect of putative 5PUTR PABP-binding
sites on CAT translation, 293-EBNA cells were transiently
transfected with the parental reporter pSV2-CAT, or pSV2-
CAT containing the 5PUTR-regulatory elements: the human
wild-type pARE (as shown in Fig. 4), 61As, 20As, and 10As,
as well as the pURE and 61Us constructs (negative controls)
(Fig. 1A). From the transcription start site, these constructs
are located either 86 nucleotides from the beginning of the
Fig. 1. The e¡ect of 5PUTR-polyadenosine on the translation and
abundance of CAT mRNA. A: Diagram of the reporter CAT con-
structs containing the predicted 5PUTR PABP-binding sites (pARE,
61As, 20As and 10As), or the polyuridine negative controls (pURE
and 61Us), under control of the SV-40 promoter. The relevant re-
striction sites, nucleotide distances and nomenclatures are indicated.
B: Human kidney 293-EBNA cells (2U105/well of 24-well plates)
were transfected with CAT constructs containing the putative PABP
binding site in its 5PUTR (described in panel A), or with the nega-
tive controls (pURE and 61Us), as well as the transfection e⁄ciency
reporter plasmid pCMVL. Three transfection reactions were done
for each experimental condition and the mean values and standard
deviations were determined (gray bars). The ratio of CAT to the L-
gal activity was set to 1 for control cells transfected with the paren-
tal pSV2-CAT vector (Ctrl. lane). NT lane indicates the non-trans-
fected 293-EBNA cells. C: 293-EBNA cells (1U106/well of six-well
plates) were transfected with the same constructs described in panel
B and Northern blot analysis of the reporter mRNAs was done us-
ing the L-gal and CAT probes. The endogenous PABP mRNA was
probed as an internal control. The CAT mRNA levels were normal-
ized to those of L-gal and PABP mRNAs (or ethidium bromide-
stained 18S rRNA). The Northern blot assays were done in tripli-
cate and the means of the normalized mRNA measurements are
shown in panel B (white bars), together with the respective CAT ac-
tivities.
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A-rich tracts or 91 nucleotides from the control U-rich se-
quences. Transfected cells were allowed to grow for 20 h prior
to harvesting and analysis of the CAT and L-gal activities (see
Section 2). As shown in Fig. 1B, all constructs containing
adenosine stretches in the reporter mRNA 5PUTR signi¢-
cantly repressed the CAT reporter activity to the same level,
regardless of the size or structure of the A-containing ele-
ments. This inhibitory e¡ect was oligo-A sequence-speci¢c
since oligo-U sequences did not block the CAT translation
as shown by the pURE and 61Us constructs, which had
the same levels of reporter activity as the parental (pSV2-
CAT) construct (Fig. 1B). These results are consistent with
those previously reported by this group, in which UV cross-
linking assays were used to show the ability of reticulocyte
PABP and GST-PABP fusions to bind the pARE of human
PABP mRNA [17]. Moreover, the speci¢city for poly(A)-
tract binding was mapped to the ¢rst and second RNA rec-
ognition motifs (RRMs) of PABP, in Xenopus [31] and yeast
[32,33].
3.2. pAREs in the 5PUTR reduce the levels of CAT mRNA in
293 cells
Since the stability of CAT mRNA is refractory to the e¡ect
of 5PUTR translation inhibitory elements [2,4,34], we decided
to analyze the CAT mRNA level of the constructs used in the
CAT activity assays (Fig. 1A). When compared to wild-type
pSV2-CAT, the presence of either the wild-type pARE or the
61 adenosines in the 5PUTR of the CAT message dramatically
decreased the mRNA levels (Fig. 1B,C). The e¡ect produced
by the pARE sequence was less intense than the pure 61As
tract, although both constructs repressed CAT activity to the
same extent. In contrast, the 61Us and pURE controls had no
e¡ect on the amount of mRNA or on CAT activity when
compared with pSV2-CAT mRNA (Figs. 1B,C). The decrease
in reporter mRNA levels induced by multiple A tracts was
proportional to the tract length. The construct containing
10As produced an equivalent amount of mRNA to that of
pSV2-CAT, while the level of pSV-20As mRNA was inter-
mediate to that in the 10As and 61As constructs, despite the
Fig. 2. The e¡ect of a single 5PUTR-tethered MS2^PABP fusion protein on the translation and abundance of CAT mRNA. A: Diagram of the
reporter CAT gene containing the MS2-binding site at 15 nt (MSC-15) or 91 nt (MSC-91) from the mRNA 5P end, and the attenuated MS2-
binding site (MSA-15) constructs. All reporter constructs were under control of the ferritin promoter. The MS2-binding stem is represented by
small letters and the nucleotide loop that alters the protein binding a⁄nity is underlined (upper panel). Diagram of the e¡ector plasmids con-
taining MS2, PABP, or the fusion protein MS2^PABP genes under control of the CMV promoter (lower panel). B: Human 293-EBNA cells
(2U105/well of 24-well plates) were co-transfected with MSC-91, pCMVL and pCDNA3 vectors (Ctrl. lane), or with the MSC-91, pCMVL and
e¡ector plasmids (MS2 and MS2^PABP lanes). The transfections were done in triplicate and the CAT activities were normalized to the L-gal
and are shown with their standard deviations. The ratio of CAT to L-gal activity was set to 1 for control cells transfected with no MS2 fusions
(gray bars). NT lane indicates the non-transfected 293-EBNA cells. C: For the mRNA measurements, 293-EBNA cells (1U106/well of six-well
plates) were transfected with the constructs described in panel B. Northern blots with 10 Wg of total RNA were done and the CAT and MS2
mRNA levels were normalized to the L-gal mRNA and ethidium bromide-stained 18S rRNA. The Northern blot assays were done in triplicate
and the means of the normalized mRNA measurements are shown in panel B (white bars), together with the respective CAT activities.
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fact that all constructs repressed CAT activity to a similar
extent (Fig. 1B). These ¢ndings, together with the observation
that the eight adenosines in tandem formed the biggest
poly(A)-pure stretch in the human wild-type pARE (Fig. 4),
indicate that potential PABP binding sites in the 5PUTR of
mRNAs can regulate the abundance and translation of re-
porter mRNA. Our results are consistent with the selection/
ampli¢cation (SELEX) assays in which human PABP [35] or
Xenopus PABP [36] molecules can bind to RNA containing a
minimum tract of 5As within an oligoribonucleotide of at
least 20 bases. X-ray structure studies have shown that the
PABP can establish electrostatic interactions through its ¢rst
two RRMs with seven consecutive adenosines (A2^A8) in
11As oligoribonucleotides [37]. These results suggest that
one RNA-bound PABP molecule can inhibit translation with-
out a¡ecting mRNA stability. Consequently, the size and
structure of the 5PUTR pAREs could independently control
the abundance and translation of reporter mRNA.
3.3. A single RNA-tethered PABP molecule can inhibit
translation without a¡ecting mRNA abundance
The mechanism of translation repression by 5PUTR-bound
proteins is well-characterized [38]. In the model system, the
iron-responsive element (IRE) stem loop present in the
5PUTR of ferritin mRNA can inhibit the attachment of the
ribosomal 40S subunit to mRNA, thereby blocking ferritin
translation when the IRE is bound to the iron regulatory
protein (IRP) [39,40]. The IRE^IRP steric blockade occurs
independently of the IRP sequence [27,34]. However, when
the IRE is placed more than 40 nucleotides away from the
cap, the inhibitory e¡ect is severely reduced [41,42]. To exam-
ine the e¡ect of a single RNA-bound PABP molecule on
mRNA translation and abundance when the RNA^protein
binding site is placed beyond the limits of steric hindrance,
we tethered the MS2^PABP fusion molecule to the 5PUTR of
CAT mRNA through the viral MS2-coat protein binding site
(Fig. 2A). Previous reports have shown that the MS2^PABP
fusion binds to the MS2 target site and retains the properties
of native PABP in vivo [12,14].
We co-transfected the CAT reporter and e¡ector plasmids
expressing MS2, PABP, or the MS2^PABP fusion protein.
The CAT assays showed that the presence of the MS2-binding
stem loop had no e¡ect on reporter translation when the
e¡ector protein was absent. However, CAT mRNA transla-
tion was inhibited by MS2^PABP binding to its 5PUTR at 91
nucleotides from the mRNA 5P end (Fig. 2B). Neither MS2
alone (Fig. 2B), nor untethered ectopically expressed PABP
(Fig. 3A) were able to block the reporter synthesis. The MS2
construct blocked CAT expression only when the MS2-bind-
ing site was inserted 15 nt downstream from the mRNA 5P
end (Fig. 3B). The e¡ect of MS2^PABP on reporter trans-
Fig. 3. The inhibition of CAT translation by PABP is dependent of
the cis elements and is abrogated by a single mutation. Plasmids en-
coding di¡erent reporter mRNAs, as well as the MS2^PABP fusion
proteins, were co-transfected in 293-EBNA cells and 20 h later the
cells were harvested and assayed for CAT and L-gal activities. Three
transfection reactions were done for each experimental condition
and the mean values and standard deviations were determined. The
ratio of CAT to L-gal activity was set to 1 for control cells trans-
fected with no MS2 fusions. A: 293-EBNA cells (2U105/well of
24-well plates) were co-transfected with MSC-91, pCMVL and
pCDNA3 vectors (Ctrl. lane), or with MSC-91, pCMVL and
pCMV-PABP plasmids (PABP lane). B: 293 cells (2U105/well of
24-well plates) were co-transfected with the reporter plasmid MSC-
15 (gray bars), or MSA-15 (black bars), together with pCMVL plus
the pCDNA3 vector (Ctrl. lane), or with pCMVL and e¡ector plas-
mids (MS2 and MS2^PABP lanes). NT lanes indicate the non-trans-
fected 293-EBNA cells.
Fig. 4. The presence of pARE at the 5PUTR of eukaryote PABP transcripts. The pARE context, including neighboring pyrimidine-rich sequen-
ces, is conserved in di¡erent PABP cDNAs. H.s., Homo sapiens (Y00345); M.m., Mus musculus (AK005009); P.m., Petromyzon marinus
(AF032896); D.m., Drosophila melanogaster (L05109); C.e., Caenorhabditis elegans (U24123); S.c., Saccharomyces cerevisiae (M12780); A.t.,
Arabidopsis thaliana (L19418); and T.b., Trypanosoma brucei (AF042190). The potential auto-regulatory PABP binding sites are underlined and
the human pARE sequence used in this study is in bold type.
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lation was attenuated when a mutation which severely reduced
the a⁄nity of MS2 for its mRNA target site was introduced in
the reporter plasmid (Fig. 3B). These results showed that the
negative e¡ect of MS2 on translation occurred only when the
cis element is present and that it was site-speci¢c. There was
no di¡erence in the amount of mRNA between assays in
which the reporter was transfected alone and assays in which
the reporter was co-transfected with the MS2 constructs (Fig.
2C). This ¢nding was consistent with the pSV-10As transfec-
tion data (Fig. 1B) and indicated that one PABP binding site
in the 5PUTR was enough to inhibit reporter translation but
did not mediate the reduction in reporter mRNA levels.
4. Discussion
In HeLa and NIH 3T3 cells, the ectopic expression of
PABP leads to a shift in endogenous PABP mRNA from
the polysomal to the post-polysomal fraction with no e¡ect
on its abundance [20,25]. In contrast, in 293 cells, overexpres-
sion of PABP does not produce a similar shift in endogenous
PABP mRNA but selectively reduces its abundance [25]. In
addition, as shown here, the presence of A-rich elements in
the 5PUTR of an otherwise stable mRNA selectively reduced
its abundance in 293-EBNA cells, and this reduction was pro-
portional to the number of putative PABP binding sites in the
A-rich element. In support of these observations, the conser-
vation of pARE within the 5PUTR of the PABP mRNAs
among di¡erent eukaryotes (Fig. 4) was indicative of a rele-
vant regulatory feature that cannot be explained solely by its
ability to repress translation, especially considering that just
10As were enough to inhibit translation to the same extent as
61As or pARE (Fig. 1B). A further observation was that the
reduced translation e⁄ciency of reporter mRNAs containing
5PUTR A-rich elements were maintained even when the num-
ber of possible PABP binding sites was reduced to one, or
when a single MS2^PABP fusion protein was tethered to
the 5P end of the mRNA, without a decrease in the amount
of reporter transcript (Figs. 2B and C). Interestingly, despite
the equivalent CAT repression produced by the wild-type
5PUTR pARE, or the arti¢cial 61As stretch, their e¡ects on
the level of CAT mRNA were distinct (Fig. 1B,C). This dis-
crepancy may re£ect di¡erences in the behavior of the PABP
multimeric-induced binding to pure adenosine and the pARE
element (Melo et al., submitted). Thus, the structure and size
of the putative 5PUTR PABP-binding sites can in£uence the
reporter mRNA level, whereas the repression of translation is
independent of the reduction in mRNA abundance.
These ¢ndings suggest that the presence of multiple PABP
molecules bound to its own 5PUTR mRNA may change the
conventional cross-talk between the poly(A) tail^PABP com-
plex, the decapping apparatus and the cap-binding complex
(eIF-4F), and lead to commitment to the mRNA decay path-
way. This hypothesis is strengthened by reports showing that
communication between eIF-4F, the decapping complex
(Dcp1p and Dcp2p), the decapping activation factors
(Lsm1p^7p) and Pab1p is the major determinant of mRNA
stability in yeast [15,43,44]. Since the autogenous repression of
PABP translation is not absolute (Fig. 1B [19,20,25]), mRNA
decay may reduce the number of PABP transcripts in the
cytoplasm, thereby avoiding the residual translation caused
by continuous PABP transcription.
In conclusion, we propose the existence of a two-way mech-
anism for controlling PABP synthesis in human 293 cells in
which mRNA translation and stability are regulated to pro-
vide the appropriate cytoplasmic level of PABP molecules.
The existence of a similar mechanism operating in other cell
types, as well as the factors which mediate this type of ex-
pression control, remain to be determined.
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